Tecentriq 1,200 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DR26FMDW5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,820
Award facts
- Contract value 100% obligated
- $39,820.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39.8K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Tecentriq (1,200 mg/20 ml vial) to support Department of Defense medical supply needs. This delivery order, issued November 12, 2025, with a firm fixed-price structure and completion date of December 4, 2025, represents a single line item procurement executed without set-aside designation. The award leverages DMS Pharmaceutical Group's established capacity as a critical supplier within the federal pharmaceutical supply chain, demonstrating the company's competitive capability in unrestricted federal procurement.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent IDC, valued at $499.9B with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3B PPV-G GEN V acquisition strategy. The contract structure authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceuticals, biologics, and medical consumables to support military healthcare facilities worldwide, with DMS Pharmaceutical Group's performance on numerous prior delivery orders demonstrating operational capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FMDW5?
SPE2DR26FMDW5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FMDW5 worth?
The government has obligated $39,820 on SPE2DR26FMDW5.
Is contract SPE2DR26FMDW5 an order under another contract?
Yes. SPE2DR26FMDW5 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMDW5 competed?
The extent of competition for SPE2DR26FMDW5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award